We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Surging Oncology Research Yields Big Approval Dividends and Lucrative Payoffs, Study Says
Surging Oncology Research Yields Big Approval Dividends and Lucrative Payoffs, Study Says
Oncology research and drug development continue to surge globally, with 159 new medications launched since 2012 — and a record 30 of those in 2021 — according to the life science research analytics firm IQVIA Institute.